Increased compliance with tumor treating fields therapy is prognostic for improved survival in the treatment of glioblastoma: a subgroup analysis of the EF-14 phase III trial（2018/11/21）

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma（2020/5/27）

Influence of Treatment With Tumor-Treating Fields on Health-Related Quality of Life of Patients With Newly Diagnosed Glioblastoma - A Secondary Analysis of a Randomized Clinical Trial（2017/11/12）

Global post‑marketing safety surveillance of Tumor Treating Fields(TTFields) in patients with high‑grade glioma in clinical practice（2020/5/21）

Improving Tumor Treating Fields Treatment Efficacy in Patients With Glioblastoma Using Personalized Array Layouts（2015/11/30）

Tumor treating fields plus temozolomide for newly diagnosed glioblastoma: a sub-group analysis of Korean patients in the EF-14 phase 3 trial

Clinical Practice Experience WithNovo TTF-100A™System for Glioblastoma: The PatientRegistry Dataset (PRiDe)”（2014/9/10　※Publish日）